Concepedia

Ervin R. Spitzmiller

ER

Statistics

Publications

12

Citations

422

H-Index

11

Active since

1947

Affiliations

Institute for Medical Research(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Sweden)

Ervin R. Spitzmiller is an author at Institute for Medical Research specializing in medicinal chemistry, pharmacology, and organic chemistry.

Publications per year

1947–1994

12

Publications

12

Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines

John Krapcho, Chester F. Turk, David W. Cushman et al. · Journal of Medicinal Chemistry · 1988 · 163 citations · Full text

, , +15

Substituted 2,3-Dihydro-1,5-benzothiazepin-4(5H)-ones and 3,4-Dihydro-2-phenyl-(2H)-1,6-benzothiazocin-5(6H)-ones

John Krapcho, Ervin R. Spitzmiller, Chester F. Turk · Journal of Medicinal Chemistry · 1963 · 72 citations

, , +8

Synthesis of 2-phosphonopyrrolidine and its substitution for proline in an inhibitor of angiotensin-converting enzyme

Edward W. Petrillo, Ervin R. Spitzmiller · Tetrahedron Letters · 1979 · 44 citations

, , +5

Orally active prodrugs of quinoline-4-carboxylic acid angiotensin II receptor antagonists

Denis E. Ryono, John Lloyd, Michael A. Poss et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 25 citations

, , +12

3,5‐Disubstituted‐1,2,4‐oxadiazoles and 4,5‐dihydro‐3,5‐disubstituted‐1,2,4‐oxadiazoles

Harry L. Yale, Ervin R. Spitzmiller · Journal of Heterocyclic Chemistry · 1978 · 20 citations

, , +11

1–5 of 12